Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $422.23 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $145.49 | 4 | $0 (2024) |
| Medtronic MiniMed, Inc. | $117.88 | 2 | $0 (2019) |
| Valeritas, Inc. | $77.73 | 1 | $0 (2018) |
| Mannkind Corporation | $20.08 | 1 | $0 (2020) |
| Abbott Laboratories | $18.64 | 1 | $0 (2022) |
| Corcept Therapeutics | $15.55 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $14.40 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.46 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.49 | 4 | Medtronic, Inc. ($145.49) |
| 2022 | $18.64 | 1 | Abbott Laboratories ($18.64) |
| 2020 | $46.94 | 3 | Mannkind Corporation ($20.08) |
| 2019 | $56.20 | 2 | Medtronic MiniMed, Inc. ($40.65) |
| 2018 | $77.73 | 1 | Valeritas, Inc. ($77.73) |
| 2017 | $77.23 | 1 | Medtronic MiniMed, Inc. ($77.23) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: Durable Pump | ||||||
| 08/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Durable Pump | ||||||
| 07/09/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $84.03 | General |
| Category: Durable Pump | ||||||
| 01/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Durable Pump | ||||||
| 12/08/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes Care | ||||||
| 02/25/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: DIABETES | ||||||
| 12/27/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 03/20/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $40.65 | General |
| Category: Durable Pump | ||||||
| 09/25/2018 | Valeritas, Inc. | V-GO (Device) | Food and Beverage | In-kind items and services | $77.73 | General |
| Category: 1 | ||||||
| 04/19/2017 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $77.23 | General |
| Category: Durable Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 177 | 241 | $64,456 | $21,770 |
| 2022 | 5 | 166 | 224 | $59,105 | $19,977 |
| 2021 | 4 | 139 | 183 | $40,499 | $17,931 |
| 2020 | 5 | 149 | 165 | $37,437 | $15,061 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 167 | $41,750 | $14,225 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $11,622 | $3,669 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 19 | $6,460 | $2,164 | 33.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,120 | $1,288 | 41.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 14 | 16 | $1,504 | $423.84 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 141 | $35,250 | $12,024 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $11,175 | $3,855 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 25 | $8,500 | $3,006 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $3,060 | $670.07 | 21.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 16 | $1,120 | $422.40 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 102 | $20,681 | $9,019 | 43.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 33 | $8,844 | $4,120 | 46.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $7,518 | $3,320 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 27 | $3,456 | $1,472 | 42.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 51 | $9,639 | $4,177 | 43.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 30 | 30 | $10,740 | $3,908 | 36.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 32 | 32 | $9,120 | $3,550 | 38.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 41 | $5,166 | $2,306 | 44.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 11 | $2,772 | $1,121 | 40.4% |
About Dr. Nini Thomas, MD
Dr. Nini Thomas, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in West Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437200557.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nini Thomas, MD has received a total of $422.23 in payments from pharmaceutical and medical device companies, with $145.49 received in 2024. These payments were reported across 12 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($422.23).
As a Medicare-enrolled provider, Thomas has provided services to 631 Medicare beneficiaries, totaling 813 services with total Medicare billing of $74,739. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location West Lafayette, IN
- Active Since 01/16/2007
- Last Updated 10/30/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1437200557
Products in Payments
- MINIMED 780G (Device) $145.49
- Minimed 670G System (Device) $117.88
- V-GO (Device) $77.73
- AFREZZA (Drug) $20.08
- FREESTYLE LIBRE (Device) $18.64
- Korlym (Drug) $15.55
- FARXIGA (Drug) $14.40
- JARDIANCE (Drug) $12.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.